Differential roles of myocardial Ca2+ channels and Na+/Ca2+ exchange in myocardial reperfusion injury in open chest dogs: Relative roles during ischemia and reperfusion

Cardiovascular Research

Volumn 36, Issue 3, 1997, Pages 337-346

  Smart, Steven C ^a   Sagar, Kiran B ^a   Warltier, David C ^a  

^a Division of Cardiology   (United States)

Author keywords

Amiloride; Dogs; Myocardial contraction; Myocardial ischemia; Nifedipine; Reperfusion arrhythmias; Reperfusion injury; Stunned myocardium

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; AMILORIDE; CALCIUM CHANNEL; NIFEDIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; HEART CONTRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE FIBRILLATION; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SODIUM CALCIUM EXCHANGE; STUNNED HEART MUSCLE;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; AMILORIDE; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NIFEDIPINE; PERFUSION; RANDOM ALLOCATION; SODIUM-CALCIUM EXCHANGER; TIME FACTORS;

EID: 0031455786     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00187-9     Document Type: Article

References (55)

1. Opie L.H. Reperfusion injury and its pharmacologic modification. Circulation. 80:1989;1049-1062.
2. Bolli R. Mechanism of myocardial 'stunning'. Circulation. 82:1990;723-738.
3. Kloner R.A., Przyklenk K., Patel B. Altered myocardial sites. The stunned and hibernating myocardium. Am J Med. 86:1989;14-22.
4. 2+ overload in reperfused ischemic myocardium. Ann Rev Physiol. 52:1990;543-559.
5. 2+] in mammalian ventricle: dynamic control by cellular process. Annu Rev Physiol. 52:1990;467-485.
6. Barry W.H., Bridge J.H.B. Intracellular calcium homeostasis in cardiac myocytes. Circulation. 87:1993;1806-1815.
7. 2+ from sarcoplasmic reticulum of guinea-pig cardiac cells. J Physiol (London). 405:1988;122-255.
8. Sperelakis N., Wahler G.M. Regulation of Ca2+ influx in myocardial cells by beta adrenergic receptors, cyclic nucleotides, and phosphorylation. Mol Cell Biochem. 82:1988;19-28.
9. + exchange is not operative under low-flow ischemic conditions. J Mol Cell Cardiol. 23:1991;505-517.
10. du Toit E.F., Opie L.H. Modulation of the severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at the onset of reperfusion. Circ Res. 70:1992;960-967.
11. Opie L.H., du Toit E.F. Postischemic stunning: the two-phase model for the role of calcium as pathogen. J Cardiovasc Pharmacol. 20:1992;S1-S4.
12. Ver Conck L., Borgers M., Verdonck F. Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principle. Cardiovasc Res. 27:1993;349-357.
13. 2+ exchange in canine cardiac sarcolemmal vesicles. Circ Res. 50:1982;287-293.
14. Higgins A.J., Blackburn K.J. Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists. J Mol Cell Cardiol. 16:1984;427-438.
15. Hamm C.W., Opie L.H. Protection of infarcting myocardium by slow channel inhibitors: Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart. Circ Res. 52:1983;I129-I138.
16. Ferrari R., Albertini A., Curello S., Ceconi C., Di Lisa F., Raddino R., Vistoli O. Myocardial recovery during post-ischaemic reperfusion: Effects of nifedipine, calcium, and magnesium. J Mol Cell Cardiol. 18:1986;487-498.
17. Watts J.A., Maiorano L.J., Maiorano P.C. Protection by verapamil of globally ischemic rat hearts: energy preservation, a partial explanation. J Mol Cell Cardiol. 17:1985;797-804.
18. Watts J.A., Maiorano L.J., Maiorano P.C. Comparison of the protective effects of verapamil, diltiazem, nifedipine, and buffer containing low calcium upon global myocardial ischemic injury. J Mol Cell Cardiol. 18:1986;255-263.
19. Lamping K.A., Gross G.J. Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine. J Cardiovasc Pharmacol. 7:1985;158-166.
20. Przyklenk K., Kloner R.A. Effect of verapamil on postischemic 'stunned' myocardium: Importance of the timing of treatment. J Am Coll Cardiol. 11:1988;614-623.
21. Przyklenk K., Ghafari G.B., Eitzman D.T., Kloner R.A. Nifedipine administered after reperfusion ablates systolic contractile dysfunction of postischemic 'stunned' myocardium. J Am Coll Cardiol. 13:1989;1176-1183.
22. 2+ exchange. Circ Res. 65:1989;1045-1056.
23. Weiss R., Lakatta E., Gerstenblith G. Effects of amiloride on metabolism and contractility during reoxygenation in perfused rat hearts. Circ Res. 66:1990;1012-1022.
24. Karmazyn M. Amiloride enhances postischemic ventricular recovery: possible role of Na/H exchange. Am J Physiol. 255:1988;H608-H615.
25. + exchange inhibitors against cardiac injury produced by ischemia/reperfusion, hypoxia/reoxygenation, and the calcium paradox. J Cardiovasc Pharmacol. 21:1993;172-178.
26. + exchanger in reperfusion stunning in isolated perfused rat heart. J Cardiovasc Pharm. 22:1993;877-883.
27. + exchange and reperfusion arrhythmias: protection by intracoronary infusion of a novel inhibitor. Am J Physiol. 167:1994;H2430-H2440.
28. Duff H.J. Clinical and in vivo antiarrhythmic potential of sodium-hydrogen exchange inhibitors. Cardiovasc Res. 29:1995;189-193.
29. Otani H., Kato Y., Ko T., Sakurai Y., Kagawa K., Tanaka K., Fukunaka M., Imamura H., Cragoe E.J. Jr. Effects of amiloride and an analog on ventricular arrhythmias, contracture, and cellular injury in isolated perfused guinea pig hearts. Japanese Circ J. 55:1991;845-856.
30. Yano K., Maruyama T., Makino N., Matsui H., Yanaga T. Effects of amiloride on the mechanical, electrical, and biochemical aspects of ischemia-reperfusion injury. Mol Cell Biochem. 121:1993;75-83.
31. 2+ channels. J Am Coll Cardiol. 26:1995;1365-1373.
32. 2+ channels. Br J Pharmacol. 116:1995;2134-2140.
33. Theroux P., Franklin D., Ross J. Jr., Kemper W.S. Regional myocardial function during acute coronary occlusion and its modification by pharmacologic agents in the dog. Circ Res. 35:1974;896-908.
34. Domenech R., Hoffman J., Noble M., Saunders K., Henson J., Subijanto S. Total and regional coronary blood flow measured by radioactive microspheres in conscious and anesthetized dogs. Circulation. 25:1969;581-596.
35. Bolli R., Zhu W., Thornby J.I., O'Neill P.G., Roberts R. Time course and determinants of recovery of function after reversible ischemia in conscious dogs. Am J Physiol. 254:1988;H102-H114.
36. + exchange. Circ Res 1990;661156-661159.
37. + exchange inhibitor on postischemic reperfusion in pig heart. J Cardiovasc Pharmacol. 23:1994;72-78.
38. 2+ exchange. Euro J Pharm. 105:1984;317-322.
39. Henry P.D. Comparative pharmacology of calcium antagonists: nifedipine, verapamil, and diltiazem. Am J Cardiol. 46:1980;1047-1058.
40. Kleyman T.R., Cragoe E.J. Jr. Amiloride and its analogs as tools in the study of ion transport. J Membrane Biol. 105:1988;1-21.
41. O'Brien P., Bosnjak Z., Warltier D.C. Recovery of contractile function of postischemic, reperfused myocardium: influence of 2,3-butanedione-2-monoxime. J Cardiovasc Pharmcol. 21:1993;693-700.
42. Nayler W.G., Elz J.S., Buckley D.J. The stunned myocardium: effect of electrical and mechanical arrest and osmolarity. Am J Physiol. 255:1988;H60-H69.
43. Ovize M., Kloner R.A., Przyklenk K. Stretch preconditions canine myocardium. Am J Physiol. 266:1994;H137-H146.
44. Mak I.T., Weglicki W.B. Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. Circ Res. 66:1990;1449-1452.
45. +. J Leukocyte Biol. 41:1987;25-32.
46. Auchampach J.A., Maruyama M., Cavero I., Gross G.J. Pharmacologic evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation. 86:1992;311-319.
47. Duff H.J., Cannon N.J., Sheldon R.S. Mexilitine-quinidine in isolated hearts: an interaction involving the sodium channel. Cardiovasc Res. 23:1989;584-592.
48. + during myocardial ischemia: Consequences for post-ischemic recovery. J Mol Cell Cardiol. 29:1997;85-96.
49. Duncker D.J., Van Zon N.S., Altman J.D., Pauck T.J., Bache R.J. Role of K+ATP channels in coronary vasodilation during exercise. Circulation. 88:1993;1245-1253.
50. Silverman H.S., Stern M.D. Ionic basis of ischaemic cardiac injury: insights from cellular studies. Cardiovasc Res. 28:1994;581-597.
51. 2+ exchange and not by its antioxidant effects. Circ Res. 70:1992;804-811.
52. Haigney M.C.P., Miyata H., Lakatta E.G., Stern M.D., Silverman H.S. Dependence of hypoxic cellular calcium loading on sodium-calcium exchange. Circ Res. 71:1992;547-557.
53. Bean B.P. Pharmacology of calcium channels in cardiac muscle, vascular muscle, and neurons. Am J Hypertension. 4:1991;406S-411S.
54. Nobe S., Aomine M., Arita M. Bepridil prolongs the action potential duration of guinea pig ventricular muscle only at rapid rates of stimulation. Gen Pharmacol. 24:1993;1187-1196.
55. Bielefeld D.R., Hadley R.W., Vassilev P.M., Hume J.R. Membrane electrical properties of vesicular Na-Ca exchange inhibitors in single atrial myocytes. Circ Res. 59:1986;381-389.